Remote controlled one-step production of 18F labeled butyrophenone neuroleptics exemplified by the synthesis of n.c.a. [18F] N-methylspiperone

Abstract A remote controlled synthesis for the routine production of [ 18 F]butyrophenones is described. The modular set-up includes a one step HPLC- and a solid phase extraction unit both connected on-line to a single unit reactor. [ 18 F]N-methylspiperone was synthesized from 8-[4-(4-nitrophenyl)-4-oxobutyl]-3-methyl-1-phenyl-1,3,8-triazaspiro [4.5]decan-4-one using the direct nucleophilic aromatic fluorination in presence of a cryptate consisting of Kryptofix® 2.2.2, potassium oxalate and a small amount of potassium carbonate (50 μg). The one-step synthesis gave radiochemical yields of 15–20% within a synthesis time of 70 min, including product formation. Starting with the appropriate amount of 18 F-fluoride up to 180 mCi [ 18 F]MSP have been obtained. The radiochemical purity is in the range of 96–98% and the specific activity is >4000 Ci/mmol. The system is generally useful for the synthesis of other n.c.a. [ 18 F]butyrophenone neuroleptics such as [ 18 F]N-methylbenperidol starting with the corresponding nitro precursors.

[1]  J. Mertens,et al.  Mechanistic approach of the nucleophilic18F‐ exchange on 4′‐NO2‐spiperone using TBA18F or K2.2.2./K18F , 1990 .

[2]  G. Sedvall,et al.  Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. , 1988, Archives of general psychiatry.

[3]  K. Hamacher,et al.  Computer-aided synthesis (CAS) of no-carrier-added 2-[18F]fluoro-2-deoxy-D-glucose: an efficient automated system for the aminopolyether-supported nucleophilic fluorination , 1990 .

[4]  C. D. Arnett,et al.  Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  S. Moerlein,et al.  Production of fluorine-18 labeled (3-N-methyl)benperidol for PET investigation of cerebral dopaminergic receptor binding. , 1992, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[6]  A. Wilson,et al.  In vivo labeling of the dopamine D2 receptor with N-11C-methyl-benperidol. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  J S Fowler,et al.  [18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain. , 1985, Life sciences.

[8]  C. D. Arnett,et al.  Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients , 1988, Biological Psychiatry.

[9]  K. Hamacher,et al.  Optimization studies concerning the direct nucleophilic fluorination of butyrophenone neuroleptics , 1993 .

[10]  H. Coenen,et al.  Preparation of N.C.A. [17‐18F]‐fluoroheptadecanoic acid in high yields via aminopolyether supported, nucleophilic fluorination , 1986 .

[11]  C. D. Arnett,et al.  Syntheses and Specific Activity Determinations of No-Carrier-Added Fluorine-18-Labeled Neuroleptic Drugs , 1985 .

[12]  T. Cooper,et al.  Dopamine receptor occupancy and plasma haloperidol levels. , 1989, Archives of general psychiatry.